France Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Pharmaceuticals in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The French pharmaceuticals market had total revenues of $74.9 billion in 2022, representing a compound annual growth rate (CAGR) of 3.7% between 2017 and 2022.
0
The French market acquired a 21.2% share of the European pharmaceuticals market in 2022. The growth in the pharmaceuticals market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in France stood at 12.5% of total health spending in 2021.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in France
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in France
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the France pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

What was the size of the France pharmaceuticals market by value in 2022?
What will be the size of the France pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the France pharmaceuticals market?
How has the market performed over the last five years?
How large is France’s pharmaceuticals market in relation to its regional counterparts?

1 Executive Summary

1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape

2 Market Overview

2.1. Market definition
2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?

8 Company Profiles

8.1. Sanofi SA
8.2. Laboratoires Pierre Fabre SA
8.3. Les Laboratoires Servier
8.4. AstraZeneca PLC

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology
10.2. Industry associations
10.3. Related research
10.4. About the Publisher

List of Tables

Table 1: France pharmaceuticals market value: $ billion, 2017-22
Table 2: France pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: France pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Sanofi SA: key facts
Table 5: Sanofi SA: Annual Financial Ratios
Table 6: Sanofi SA: Key Employees
Table 7: Sanofi SA: Key Employees Continued
Table 8: Laboratoires Pierre Fabre SA: key facts
Table 9: Laboratoires Pierre Fabre SA: Key Employees
Table 10: Les Laboratoires Servier: key facts
Table 11: Les Laboratoires Servier: Key Employees
Table 12: AstraZeneca PLC: key facts
Table 13: AstraZeneca PLC: Annual Financial Ratios
Table 14: AstraZeneca PLC: Key Employees
Table 15: AstraZeneca PLC: Key Employees Continued
Table 16: France size of population (million), 2018-22
Table 17: France gdp (constant 2005 prices, $ billion), 2018-22
Table 18: France gdp (current prices, $ billion), 2018-22
Table 19: France inflation, 2018-22
Table 20: France consumer price index (absolute), 2018-22
Table 21: France exchange rate, 2018-22

List of Figures

Figure 1: France pharmaceuticals market value: $ billion, 2017-22
Figure 2: France pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: France pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in France, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in France, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in France, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in France, 2022

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Sanofi SA
Laboratoires Pierre Fabre SA
Les Laboratoires Servier
AstraZeneca PLC

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€344EUR$350USD£287GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€515EUR$525USD£431GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€687EUR$700USD£574GBP

Key Highlights

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

The Corporate Reputation of Pharma in 2023/2024: The Patient Perspective (Global Edition) - The Views of 2,500+ Patient Groups Worldwide

The Corporate Reputation of Pharma in 2023/2024 - The Patient Perspective - Cancer Edition - The Views of 520 Cancer Patient Groups

Co-Development Deals in Pharmaceuticals and Biotechnology 2016 to 2024

Industry Snapshots: France Pharmaceutical

Company Snapshots: France Pharmaceutical